Duran Duran’s Andy Taylor Shares The Drug He Took For Cancer Extended His Life By 5 Years
Andy Taylor, a former guitarist for Duran Duran, claims that the medication he uses to treat his prostate cancer has given him an additional five years of life.
In a January interview, Taylor, 62, spoke candidly about having stage 4 metastatic prostate cancer. About four years earlier, he had received the disease’s official diagnosis. Due to continuous treatment, the artist was compelled to skip the 2022 Rock and Roll Hall of Fame ceremony last November.
How Targeted Treatment Altered Taylor’s Journey
Founder of the Cancer Awareness Trust Prof Sir Chris Evans contacted Taylor after he went public with his battle with cancer to give him “a nuclear medicine, Lutetium-177, which is targeted so it only sees cancer cells,” Taylor said in a statement to BBC Breakfast on August 11. He added:
“It can’t see healthy cells. It kills stage four cancer in your bones. And so what it’s effectively done is extend my life for five years.”
Taylor had his first round of this new treatment six weeks ago and is scheduled for another round next week. He mentioned that he had to improve his overall health significantly before receiving this treatment. He expressed his desire to continue working despite his health condition, describing the medication as “a little beacon of hope” that has enabled him to work again.
Long-Awaited Solo Album
Man’s A Wolf To Man, Taylor’s first solo album in over 30 years, will be released on September 8th. He also talked about how his health prevented him from attending Duran Duran’s induction into the Rock and Roll Hall of Fame last year.
On August 19, the band will perform a charity show in his honor, with all revenues going to the Cancer Awareness Trust. It was also reported earlier this year that Duran Duran has been collaborating with Taylor on a new album.